Investigational biologic may reduce need for systemic corticosteroids in patients with severe asthma
An investigational biologic may reduce the need for adults with severe asthma to take an oral corticosteroid to control their asthma, according to a randomized controlled trial presented at the ATS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results